Ester Dunnebach
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia.
Journal: Haematologica
Published: April 18, 2024
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
Journal: Journal for immunotherapy of cancer
Published: March 18, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.
Journal: Journal for immunotherapy of cancer
Published: December 18, 2023
Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer.
Journal: Frontiers in immunology
Published: September 26, 2022
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch.
Journal: Journal for immunotherapy of cancer
Published: September 22, 2022
Heterozygous Variants in the DNA-binding Domain of c-Myb May Affect Normal B/T Cell Development.
Journal: HemaSphere
Published: January 06, 2022
Efficient lentiviral transduction method to gene modify cord blood CD8+ T cells for cancer therapy applications.
Journal: Molecular therapy. Methods & clinical development
Published: November 11, 2020
Clinical Grade Production of Wilms' Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation.
Journal: Frontiers in immunology
Published: May 05, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026